1. Home
  2. SAGE vs RWAY Comparison

SAGE vs RWAY Comparison

Compare SAGE & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • RWAY
  • Stock Information
  • Founded
  • SAGE 2010
  • RWAY 2015
  • Country
  • SAGE United States
  • RWAY United States
  • Employees
  • SAGE N/A
  • RWAY N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • RWAY
  • Sector
  • SAGE Health Care
  • RWAY
  • Exchange
  • SAGE Nasdaq
  • RWAY Nasdaq
  • Market Cap
  • SAGE 444.1M
  • RWAY 428.4M
  • IPO Year
  • SAGE 2014
  • RWAY 2021
  • Fundamental
  • Price
  • SAGE $7.31
  • RWAY $11.63
  • Analyst Decision
  • SAGE Hold
  • RWAY Buy
  • Analyst Count
  • SAGE 20
  • RWAY 9
  • Target Price
  • SAGE $10.67
  • RWAY $11.89
  • AVG Volume (30 Days)
  • SAGE 1.8M
  • RWAY 216.1K
  • Earning Date
  • SAGE 02-11-2025
  • RWAY 03-20-2025
  • Dividend Yield
  • SAGE N/A
  • RWAY 15.39%
  • EPS Growth
  • SAGE N/A
  • RWAY N/A
  • EPS
  • SAGE N/A
  • RWAY 1.02
  • Revenue
  • SAGE $41,243,000.00
  • RWAY $150,078,000.00
  • Revenue This Year
  • SAGE $123.13
  • RWAY N/A
  • Revenue Next Year
  • SAGE $69.65
  • RWAY N/A
  • P/E Ratio
  • SAGE N/A
  • RWAY $11.35
  • Revenue Growth
  • SAGE N/A
  • RWAY N/A
  • 52 Week Low
  • SAGE $4.62
  • RWAY $9.87
  • 52 Week High
  • SAGE $23.22
  • RWAY $13.74
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 60.55
  • RWAY 64.40
  • Support Level
  • SAGE $7.00
  • RWAY $11.30
  • Resistance Level
  • SAGE $7.26
  • RWAY $11.67
  • Average True Range (ATR)
  • SAGE 0.19
  • RWAY 0.14
  • MACD
  • SAGE -0.06
  • RWAY -0.01
  • Stochastic Oscillator
  • SAGE 57.14
  • RWAY 76.74

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About RWAY Runway Growth Finance Corp.

Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and Canada, with the majority of its portfolio invested in the United States.

Share on Social Networks: